Medicare's new $2,000 prescription drug cap goes into effect. Here's how it works.
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...
FDA’s New Guidance Plan to Face Trump's Transparency Efforts
A revamped plan to streamline the FDA’s guidance practices stands to be tested as President-elect Donald Trump looks to ...
US FDA restricts imports of some Viatris drugs made at India facility
Viatris said on Monday the U.S. Food and Drug Administration has restricted imports of 11 products made at the drugmaker's ...
Drugmakers to raise US prices on over 250 medicines starting Jan. 1
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...
Blame The Game Or The Players? Regulating Pharmacy Benefit Managers
For pharmacy benefit managers, our new Congress should focus on removing the flawed rules to improve the game rather than ...
The PBM Bill Failed. Americans Dodged A Bullet.
The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board ...
Access to medication is increasingly being dictated by preferred pharmacy networks
Major insurers say the deals are essential to controlling costs, but critics say they may be driving up costs and unfairly ...
Halozyme: 'Accidental' Business Model Has Exciting Upside Opportunities In 2025
Halozyme provides subcutaneous drug delivery solutions, with several major new products recently approved. Click here to find ...
Crain's Chicago Business9d
A Northwestern-born startup has new ownership — and a new focus
After years of restructuring, Chicago-based Exicure has South Korean majority ownership and is buying the U.S. arm of a South ...
Viatris confirms receipt of warning letter, import alert for India facility
Our plants around the world are regularly inspected by health authorities to ensure compliance with the various markets we serve. Following an inspection by the U.S. FDA at our oral finished dose ...
UnitedHealth and CVS Received Millions in Opioid Rebates Through Medicare
As the U.S. opioid crisis deepened, Medicare plans administered by UnitedHealth and CVS Health were a top source of OxyContin ...
Business Insider26d
FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALS
Clene will meet with the FDA in early 2025 to review and finalize its statistical analysis plan for the EAP NfL biomarker analyses. Survival Pharmacometric Modeling: Provide analyses of NfL and ...